Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
184 participants
INTERVENTIONAL
2007-08-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Pain Control Orthopedic Trauma
NCT02100163
Water-friendly Virtual Reality and Brief Thermal Pain
NCT04245475
Virtual Reality Analgesia for Brief Thermal Pain
NCT05130307
Virtual Reality Pain Study
NCT05293275
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
NCT04851301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Virtual Reality Hypnosis
Virtual Reality
Using Virtual Reality for pain control
2
Virtual Reality Distraction
Virtual Reality
Using Virtual Reality for pain control
3
Standard treatment.
Virtual Reality
Using Virtual Reality for pain control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality
Using Virtual Reality for pain control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Compliant and able to complete questionnaires
* Hospitalization for internal injuries requiring a laparotomy or for orthopedic injuries (closed long bone or calcaneus fractures).
* A minimum of 3 days hospitalization
* No history of psychiatric (DSM-IV-R Axis I) disorder
* Not demonstrating delirium, psychosis or any form of Organic Brain Disorder
* Able to communicate verbally
* Able to take oral medications
* Baseline pain level of \>=5/10
* English-speaking
Exclusion Criteria
* Not capable of indicating pain intensity
* Not capable of filling out study measures
* Hospitalization of less than 3 days
* Evidence of traumatic brain injury
* History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes.
* Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems.
* Unable to communicate orally.
* Unable to take oral medications
* History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment
* Receiving prophylaxis for alcohol or drug withdrawal
* Developmental disability
* Mini-mental status score of greater than 20 in patients older than 80 years or suspected of cognitive deficits
* Non-English Speaking
* Extreme susceptibility to motion sickness
* Seizure history
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
National Institute of General Medical Sciences (NIGMS)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Patterson
PhD. ABPP. Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David R Patterson, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington; Harborview Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30359-G
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.